Skip to main content
Journal of Radiation Research logoLink to Journal of Radiation Research
letter
. 2024 Feb 6;65(2):259–261. doi: 10.1093/jrr/rrae002

Evaluating thyroid cancer risks for nuclear workers related to the Fukushima Daiichi Nuclear Power Plant accident based on LNT theory is problematic

Bobby R Scott 1,
PMCID: PMC10959441  PMID: 38321603

Dear Editor,

I read with great interest the recent study by Tatsuzaki et al. [1], which focused on abnormal thyroid function among seven Fukushima Daiichi Nuclear Power Plant (FDNPP) accident victims (emergency nuclear workers) from more than 24 000 workers, who had internal radiation exposure due to intakes of radionuclides (mainly I-131). The indicated seven individuals (all men) were followed for 10 years after the accident and were thought to have received the highest committed equivalent radiation doses to the thyroid (3.2–12 Sv). According to the researchers, none of the workers had symptoms demonstrating abnormal thyroid function. However, there are plans for longer follow-up of the seven workers. This letter intends to supplement the paper by Tatsuzaki et al. [1] by pointing out the need for a large epidemiologic study of thyroid cancer among the FDNPP workers and also pointing out biasing procedures (associated with poorly designed studies) to avoid. Including workers exposed to low radiation doses (e.g. 0–0.5 Sv) to the thyroid is recommended.

It is important to avoid a poorly designed epidemiologic study of cancer risk, especially when considering low radiation doses. Poorly designed studies that relate to cancer risks for low radiation doses (e.g. see literature [2–5]) employ misinforming procedures that yield results that promote radiation-phobia-related harm [6]. Radiation phobia has already caused enormous societal losses for Japanese citizens following the FDNPP accident, related to the highly stressed elderly evacuees [6]. The phobia is linked to the unscientific linear no-threshold (LNT) cancer risk model, whereby any amount of radiation, no matter how small, can cause cancer (e.g. thyroid cancer), and cancer risk increases linearly as radiation dose increases; however, extensive radiobiological data related to adaptive-response-associated, chemico-biological interactions in the body and their consequences essentially invalidate LNT as applied to cancer induction by ionizing radiation [7, 8].

Presently, justification for use of LNT in epidemiologic studies focused on low radiation doses is unfortunately based on misinforming procedures used that essentially guarantee an apparent LNT dose–response relationship for relative risk (RR) and related excess relative risk (ERR) for cancer induction (or cancer mortality) [6]. Some misinforming procedures employed by some epidemiologists are presented in Table 1 and elsewhere [6, 9]. A key misinforming procedure to avoid is using LNT as the null hypothesis (implied by using an LNT model and including high dose data [6, 9]), rather than assuming no radiogenic harm (e.g. for low doses). When LNT is considered the null hypothesis, uncertainty in RR and ERR is modeled to progressively vanishing as dose decreases toward the assigned zero dose group, with essentially no uncertainty about elevated risk remaining at a dose of 1 nGy; with 1 nGy being treated as definitely harmful for someone in a very large population. This is permitted because uncertainty for the estimate RR = 1 for the zero-dose group (actually exposed to natural background radiation) is omitted [9]. Including this uncertainty can lead to results that support a threshold [9], as clarified in the next paragraph. For examples of intentionally and unscientifically vanishing existing uncertainty, see these LNT applications [2–5] by epidemiologists. Reviewers for at least one of the papers [3] appear to be unaware of the use of misinforming procedures by the researchers, as evidenced by reviewer comments available via the journal.

Table 1.

Misinforming procedures used by some epidemiologists when trying to justify use of the LNT risk model for assessing cancer risk for low radiation doses [6, 9]

Number Misinforming procedure
1 For the supposedly un-irradiated group, assigning the estimate RR = 1 no uncertainty, even though the absolute risk used to evaluate RR has >0 uncertainty.
2 Lagging the protracted exposure dose (i.e. discarding some of the dose) even when the dose is too small to likely cause any harm, thereby blaming each cancer on radiation exposure irrespective of the true cause.
3 Treating the assigned unexposed group as having never been irradiated via natural background or other radiation sources.
4 Including high-dose data to guarantee a positive slope to the forced fitted LNT line.
5 Using dose groups with a wide range of doses, which can hide nonlinearity. Modern data analysis methods allow for individual data points to be used with risk replaced with a Bernoulli random variable (1 for cancer present; 0 for cancer absent), in which case individual-specific doses rather than dose groups can be used along with conditional logistic regression in modeling cancer risk. For an example of modern data analysis methods, see Thompson’s analysis of lung cancer probability related to radon inhalation in the home [10].
6 Using LNT for cancer induction as the null hypothesis rather than assuming no radiation harm (e.g. for low doses).

The misleading nature of inappropriately vanishing risk uncertainty is reflected by the fact that absolute risk estimates, upon which RR and ERR estimates are based, have >0 uncertainties; thus, uncertainty should not vanish, even for the estimated RR = 1 for the assigned zero dose group [9]. The missing uncertainty can be evaluated by assuming a lognormal distribution of RR estimates or by using a binominal distribution of the cases count associated with absolute risk [9]. Both approaches would be expected to yield very similar results for the lower (L95) and upper (U95) 95% confidence interval values, respectively, associated with the estimated RR = 1. When evaluating ERR, adjustment for the indicated missing uncertainty for RR = 1 for the assigned zero dose group needs to be performed, which unfortunately is seldom done [e.g. see literature 2, 5] by LNT-using epidemiologists. The cited reference [9] relates to alpha-radiation-caused lung cancer in humans. Making the needed adjustment can lead to results supportive of a population threshold (i.e. the greater than zero radiation dose needed to cause cancer of a specific type in the most radiosensitive member of a population). When only risk increases above the U95 were considered scientifically defendable ERR for lung cancer induction, a population threshold dose >20 mGy was implicated for alpha radiation [9]. Note that a 20 mGy absorbed dose corresponds to a 400 mSv equivalent dose. For doses below a population threshold, no cancers of the type of interest are induced by radiation in anyone in an irradiated population; however, the threshold likely differs for different populations, cancer types and radiation exposure scenarios [9].

The need to account for the missing risk uncertainty was apparently recognized by Tatsuzaki et al. [1] when discussing results of an epidemiologic study of thyroid cancer among Chernobyl liquidators [11]. Hopefully the information provided in this letter will help in designing additional studies of cancer risk associated with radiation exposures related to the FDNPP accident that do not by design promote more potentially harmful radiation phobia on top of what already exists in Japan [12]. Possibly, suggestive evidence for a population threshold for cancer induction will be found, as was the case for Chernobyl liquidators, where no evidence of harm for doses <300 mGy to the thyroid were pointed out by Tatsuzaki et al. [1]. If so, it will be important to characterize the population threshold dose uncertainty, as has now been done for lung cancer among Mayak plutonium facility workers exposed internally to high-LET alpha radiation [9].

Unlike modern-science-devoid LNT theory, the notion of a population dose threshold for cancer induction is consistent with modern radiobiology associated with radiation adaptive responses after low radiation doses and dose rates, as reviewed elsewhere [7, 8]. The multiple natural defenses enhanced by low radiation doses and dose rates that are linked to radiation adaptation in vivo are gifts of evolution that serve as barriers against cancer [7, 13]. Below the population threshold dose, these radiation adaptive responses can provide health benefits, including a significant reduction in cancer risks associated with exposure to other carcinogens [7, 13–15] and possibly reducing, for a period of time, the severity of some diseases including Alzheimer’s [16, 17].

It is quite important to be aware of the harm that radiation phobia, linked to LNT theory, can cause for emergency nuclear workers exposed to I-131 and other radiation sources following the FDNPP accident. Hopefully, this letter will help prevent such avoidable harm from occurring.

CONFLICT OF INTEREST

None.

Funding

None.

Data availability

Not applicable.

Authors’ contributions

Not applicable.

Presentation at conference

None.

References

  • 1. Tatsuzaki H, Kishimoto R, Kurihara O, et al.  No evidence of thyroid consequences in seven nuclear workers at the Tokyo electric power company Fukushima Daiichi nuclear power plant accident: 10-year follow-up results of thyroid status. J Radiat Res  2023;64:294–9. 10.1093/jrr/rrac092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ozasa K, Shimizu Y, Suyama A, et al.  Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases. Radiat Res  2012;177:229–43. [Published erratum appears in Radiat Res 2013;179(4):e40–e41]. 10.1667/RR2629.1. [DOI] [PubMed] [Google Scholar]
  • 3. Richardson DB, Leuraud K, Laurier D, et al.  Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ  2023;382:e074520. 10.1136/bmj-2022-074520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Gillies M, Haylock R, Hunter N, Zhang W. Risk of leukemia associated with protracted low-dose radiation exposure: updated results from the National Registry for radiation workers study. Radiat Res  2019;192:527–37. 10.1667/RR15358.1. [DOI] [PubMed] [Google Scholar]
  • 5. Sakata R, Preston DL, Brenner AV, et al.  Radiation-related risk of cancers of the upper digestive tract among Japanese atomic bomb survivors. Radiat Res  2019;192:331–44. 10.1667/RR15386.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Scott BR. Some epidemiologic studies of low-dose-radiation cancer risks are misinforming. Dose Response  2021;19:15593258211024499. 10.1177/15593258211024499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Scott BR, Tharmalingam S. The LNT model for cancer induction is not supported by radiobiological data. Chem Biol Interact  2019;301:34–53. 10.1016/j.cbi.2019.01.013. [DOI] [PubMed] [Google Scholar]
  • 8. Tubiana M, Aurengo A, Averbeck D, et al.  Dose–effect relationships and the estimation of the carcinogenic effects of low doses of ionizing radiation. Joint Report no. 2. Académie Nationale de Médecine, Institut de France—Académie des Sciences, 2005, Edition Nucleon (Paris 2005) ISBN 2-84332- 018-6.
  • 9. Scott BR. A revised system of radiological protection is needed. Health Phys  2024; in press. [DOI] [PubMed] [Google Scholar]
  • 10. Thompson RE. Epidemiological evidence for possible radiation hormesis from radon exposure: a case-control study conducted in Worcester, MA. Dose Response  2011;9:59–75. 10.2203/dose-response.10-026.Thompson. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kesminiene A, Evrard AS, Ivanov VK, et al.  Risk of thyroid cancer among Chernobyl liquidators. Radiat Res  2012;178:425–36. 10.1667/RR2975.1. [DOI] [PubMed] [Google Scholar]
  • 12. Liu M, Matsunaga H, Orita M, et al.  Risk perception of genetic effects and mental health among residents of Kawauchi village, 10 years after the Fukushima Daiichi nuclear power plant accident. J Radiat Res  2022;63:261–3. 10.1093/jrr/rrab108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Scott BR. Radiation-hormesis phenotypes, the related mechanisms and implications for disease prevention and therapy. J Cell Commun Signal  2014;8:341–52. 10.1007/s12079-014-0250-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Sakai K, Nomura T, Ina Y. Enhancement of bio-protective functions by low dose/dose-rate radiation. Dose Response  2006;4:327–32. 10.2203/dose-response.06-115.Sakai. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Sakai K, Hoshi Y, Nomura T, et al.  Suppression of carcinogenic process in mice by chronic low dose rate gamma-irradiation. Int J Low Radiat  2003;1:142–6. 10.1504/IJLR.2003.003485. [DOI] [Google Scholar]
  • 16. Cuttler JM, Abdellah E, Goldberg Y, et al.  Low doses of ionizing radiation as a treatment for Alzheimer’s disease: a pilot study. J Alzheimers Dis  2021;80:1119–28. 10.3233/JAD-200620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kaul PDD, Ehret F, Roohani S, et al.  Radiotherapy in Alzheimer’s disease: a systematic review. Int J Radiat Oncol Biol Phys  2023. 10.1016/j.ijrobp.2023.11.044. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from Journal of Radiation Research are provided here courtesy of Oxford University Press

RESOURCES